Couverture de The Dales Report | Trade to Black

The Dales Report | Trade to Black

The Dales Report | Trade to Black

De : Dales Media Group
Écouter gratuitement

We are a business news platform that provides the latest and best insight into the stories that make headlines worldwide. From cannabis to psychedelics, crypto and more, we give institutional and retail investors an inside edge in the competitive world of investing. And we profile companies that are making waves in their ever-growing industries. We are The Dales Report. The information provided in this podcast is for educational purposes only and should not be considered as financial or investment advice. Listeners are encouraged to conduct their own research and coDales Media Group Economie Finances privées
Épisodes
  • The Cannabis Stocks Institutions Actually Want | TDR Cannabis in 5

    The Cannabis Stocks Institutions Actually Want | TDR Cannabis in 5
    Jun 5 2026
    In the latest TDR Cannabis in Five presented by Flowhub, host Shadd Dales breaks down a story first reported by Forbes contributor Javier Hasse that asks a simple but important question:If there are dozens of publicly traded cannabis companies, why does Wall Street seem focused on only a handful of them?According to the analysis, only a small group of U.S. cannabis operators have reached the level of profitability and scale that typically attracts meaningful institutional capital.That group includes:Curaleaf Holdings (TSX: CURA) (OTCQX: CURLF)Green Thumb Industries (CSE: GTII) (OTCQX: GTBIF)Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF)Verano Holdings Corp. (Cboe Canada: VRNO) (OTCQX: VRNOF)Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)Ascend Wellness Holdings (CSE: AAWH.U) (OTCQX: AAWH)Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF)Glass House Brands (CBOE CA: GLAS.A.U) (OTCQX: GLASF)Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF)But is that the whole story?Shadd also looks at why companies such as:continue attracting investor attention despite sitting outside the industry’s top profitability tier.As cannabis reform continues moving forward, institutional investors aren’t simply asking whether cannabis is investable anymore.They’re asking which companies are best positioned to benefit.#CannabisStocks #CannabisInvesting #CannabisNews #MSOS #Curaleaf #GreenThumb #Trulieve #GlassHouse #Jushi #Flowhub #CannabisInvestors #Investors #StocksWant to see more Cannabis Reform?🎬 • Cannabis Stocks Arrive On Robinhood | TDR ... 🎬 • Why Virginia’s Governor Really Vetoed Cann... 🎬 • IRS Tax Guidance Could Boost Cannabis Prof... 🎬 • The Most Important Cannabis Hearing Yet | ... Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook: / thedalesreport ✅ Twitter: / thedalesreport ✅ Instagram: / dalesreport ✅ LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    8 min
  • The Uplisting Blueprint Is Taking Shape | TTB Presented by Flowhub

    The Uplisting Blueprint Is Taking Shape | TTB Presented by Flowhub
    Jun 5 2026
    In this episode of Trade To Black presented by Flowhub, hosts Shadd Dales and Anthony Varrell break down one of the most important cannabis capital markets developments we’ve seen in years.Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) has unveiled a corporate structure that could provide the first real roadmap for U.S. cannabis operators seeking access to senior U.S. stock exchanges under the current federal framework. By separating its medical cannabis operations from its adult-use business, Trulieve may have created a path toward NYSE eligibility while maintaining exposure to the broader cannabis market.What does this mean for the future of cannabis uplisting? Does this move signal that management teams are actively preparing for exchange access? And what should investors be paying attention to next?In Segment 2, Anthony Coniglio, CEO of NewLake Capital Partners (OTCQX: NLCP), joins the show to discuss the growing momentum surrounding cannabis capital markets. We get his thoughts on institutional interest, the impact of recent reverse stock splits, and whether the industry is getting closer to attracting meaningful Wall Street participation.Like, subscribe, and leave your comments!#CannabisStocks #MSOS #CannabisInvesting #Trulieve #NewLakeCapital #NYSE #Nasdaq #CannabisNews #CannabisIndustry #TradeToBlackWant to see more Cannabis Reform?🎬 • Cannabis Stocks Arrive On Robinhood | TDR ... 🎬 • Why Virginia’s Governor Really Vetoed Cann... 🎬 • IRS Tax Guidance Could Boost Cannabis Prof... 🎬 • The Most Important Cannabis Hearing Yet | ... Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook: / thedalesreport ✅ Twitter: / thedalesreport ✅ Instagram: / dalesreport ✅ LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    52 min
  • What Needs To Happen For The CBD Pilot To Succeed | Trade to Black

    What Needs To Happen For The CBD Pilot To Succeed | Trade to Black
    Jun 4 2026
    In our latest Trade To Black Podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell continue their weekly Vantage Standard series with Dr. Paul Shields, Chief Medical Officer at Vantage Hemp.This week’s segment tackles a question that continues to come up across healthcare, cannabis, and cannabinoid medicine:Why are so many doctors still hesitant to recommend CBD?The answer may have less to do with the science and more to do with education.Dr. Shields explains why many practicing physicians were never taught about the endocannabinoid system, cannabinoids, or CBD during medical school. As a result, millions of patients are already using CBD products while many healthcare providers are still trying to catch up.The episode also covers the growing Medicare CBD pilot program, the role of FDA guidance, why physician education remains a major hurdle, and what needs to happen before CBD becomes a more widely accepted part of modern healthcare.One statistic that stood out: roughly half of adult patients have tried CBD, while an estimated 10% are actively using it today for issues such as pain, anxiety, sleep, and inflammation.Dr. Shields also shares his thoughts on how healthcare systems responded to GLP-1 medications, what lessons can be learned from past pharmaceutical adoption cycles, and why properly designed clinical data could ultimately determine the future of CBD in medicine.As cannabinoid medicine continues moving closer to the mainstream, physicians, healthcare providers, regulators, and patients are all trying to answer the same question:Log on and leave your comments!00:00:00 – Why Doctors Resist CBD00:01:03 – The CBD Education Gap00:03:21 – FDA Guidance Could Change Everything00:06:33 – Medicine's History of Getting It Wrong00:10:12 – Who Will Educate Physicians on CBD?00:11:50 – The Biggest Risk to the CBD Pilot00:16:18 – CBD as Supplemental Therapy, Not a Cure00:20:40 – The Metrics That Will Determine Success00:22:10 – Building a Scalable CBD Healthcare Model00:23:18 – Why CBD Could Become Mainstream Medicine#CBD #CannabisMedicine #VantageStandard #VantageHemp #CBDResearch #Cannabinoids #HealthcareInnovation #MedicalCannabis #TradeToBlack #FlowhubWant to see more Cannabis Reform?🎬 • Cannabis Stocks Arrive On Robinhood | TDR ... 🎬 • Why Virginia’s Governor Really Vetoed Cann... 🎬 • IRS Tax Guidance Could Boost Cannabis Prof... 🎬 • The Most Important Cannabis Hearing Yet | ... Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook: / thedalesreport ✅ Twitter: / thedalesreport ✅ Instagram: / dalesreport ✅ LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    26 min
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment